 |
|
|
| |
DACLATASVIR COMBINED WITH PEGINTERFERON ALFA 2A ALFA-AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 2 OR 3 INFECTION: COMMAND GT 2/3 STUDY
|
| |
| |
Reported by Jules Levin
EASL 2013 Amsterdam April 27, 2013
Dore GJ, Lawitz E, Hézode C, Shafran S, Ramji A, Tatum H, Taliani G, Tran A,
Brunetto M, Zaltron S, Strasser S, Weis N, Ghesquiere W, Lee S, Larrey D, Pol S, Harley H, George J, Fung S, de Lédinghen V, Hagens P, Cohen D, Cooney E,
Noviello S, Hughes EA
|
| |
|
|
|
|
|
